Skip to main content
SpringerLink
Log in

Adjuvant Therapy in Patients with Pancreatic Cancer

  • Chapter
Pancreatic Cancer

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 177))

  • 1167 Accesses

Abstract

The prognosis for patients with pancreatic cancer is still very poor. A complete (R0) surgical resection of the tumor poses the only chance of cure. At the moment only postoperative chemotherapy with gemcitabine has significantly delayed the development of recurrent disease and showed an improvement in long-term survival compared to observation alone. It is essential to develop more effective adjuvant therapy strategies with involvement of all therapeutic options to change the disappointing situation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 209.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrams RA, Grochow LB, Chakravarthy A, et al. (1999) Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19–9 levels. Int J Radiat Oncol Biol Phys 44:1039–1046

    Article  PubMed  CAS  Google Scholar 

  2. Amano H, Takada T, Kato H, et al. (1999) Five-year results of a randomized study of postoperative adjuvant chemotherapy for resected pancreatic-biliary carcinomas (meeting abstract). ASCO 1999

    Google Scholar 

  3. Bakkevold KE, Arnesjo B, Dahl O, et al. (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater—results of a controlled, prospective, randomised multicentre study. Eur J Cancer 29A:698–703

    Article  PubMed  CAS  Google Scholar 

  4. Beger HG, Gansauge F, Buchler MW, et al. (1999) Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer: significant reduction in occurrence of liver metastasis. World J Surg 23:946–949

    Article  PubMed  CAS  Google Scholar 

  5. Beger HG, Link KH, Gansauge F (1998) Adjuvant regional chemotherapy in advanced pancreatic cancer: results of a prospective study. Hepatogastroenterology 45:638–643

    PubMed  CAS  Google Scholar 

  6. Buchler M, Friess H, Malfertheiner P, et al. (1990) Studies of pancreatic cancer utilizing monoclonal antibodies. Int J Pancreatol 7:151–157

    PubMed  CAS  Google Scholar 

  7. Buchler M, Friess H, Schultheiss KH, et al. (1991) A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer 68:1507–1512

    Article  PubMed  CAS  Google Scholar 

  8. Burris HA 3rd, Moore MJ, Andersen J, et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

    PubMed  CAS  Google Scholar 

  9. Chakravarthy A, Yeo C (1998) Preliminary result of a phase II study of adjuvant combined modality therapy for resected pancreatic and periampullary adenocarcinoma using local irradiation, 5-FU, leucovorin, dipyridamole and mitomycin-C (meeting abstract). ASCO 1998

    Google Scholar 

  10. Demols A, Peeters M, Polus M, et al. (2005) Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian phase II study. Int J Radiat Oncol Biol Phys 62:1351–1356

    Article  PubMed  CAS  Google Scholar 

  11. Friedman N, Brenner MJ, Linder JA, Bosley JA, Burdick RK, Didolkar MS (1999) Adjuvant radiation and continuous 5-FU followed by gemcitabine as adjuvant treatment for resected pancreatic cancer (meeting abstract). ASCO 1999

    Google Scholar 

  12. Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59:2006–2010

    Article  Google Scholar 

  13. Griffin JF, Smalley SR, Jewell W, et al. (1990) Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990 66:56–61

    Article  CAS  Google Scholar 

  14. Hoffman JP, Lipsitz S, Pisansky T, et al. (1998) Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group study. J Clin Oncol 1998 16:317–323

    CAS  Google Scholar 

  15. Ishikawa O, Ohigashi H, Imaoka S, et al. (1997) Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer. Hepatogastroenterology 1997 44:1541–1546

    CAS  Google Scholar 

  16. Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899–903

    PubMed  CAS  Google Scholar 

  17. Kayahara M, Nagakawa T, Ueno K, et al. (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993 72:2118–2123

    Article  CAS  Google Scholar 

  18. Kudrimoti M, Regine W, John W, et al. (1999) Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I/II study (meeting abstract). ASCO 1999

    Google Scholar 

  19. Lillemoe KD, Pitt HA (1996) Palliation. Surgical and otherwise. Cancer 78:605–614

    PubMed  CAS  Google Scholar 

  20. Lygidakis NJ, Sgourakis G, Georgia D, et al. (2002) Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study. Ann Surg 2002 236:806–813

    Article  Google Scholar 

  21. Lygidakis NJ, Stringaris K (1996) Adjuvant therapy following pancreatic resection for pancreatic duct carcinoma: a prospective randomized study. Hepatogastroenterology 43:671–680

    PubMed  CAS  Google Scholar 

  22. Morganti AG, Trodella L, Valentini V, et al. (1999) Preoperative radiochemotherapy in pancreatic cancer: preliminary results. Tumori 1999 85:S27–32

    CAS  Google Scholar 

  23. Neoptolemos JP, Dunn JA, Stocken DD, et al. (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001 358:1576–1585

    Article  CAS  Google Scholar 

  24. Neoptolemos JP, Stocken DD, Dunn JA, et al. (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001 234:758–768

    Article  CAS  Google Scholar 

  25. Neoptolemos JP, Stocken DD, Friess H, et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210

    Article  PubMed  CAS  Google Scholar 

  26. Oettle H, Post S, Neuhaus P, et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277

    Article  PubMed  CAS  Google Scholar 

  27. Oettle H, Riess H (2002) Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer. Cancer 95:912–922

    Article  PubMed  CAS  Google Scholar 

  28. Ozaki H, Kinoshita T, Kosuge T, et al. (1990) Effectiveness of multimodality treatment for resectable pancreatic cancer. Int J Pancreatol 1990 7:195–200

    CAS  Google Scholar 

  29. Picozzi V (2003) Adjuvant therapy for resected pancreas cancer (PC) using alpha-interferon (IFN)-based chemoradiation: completion of a phase II trial. ASCO 2003

    Google Scholar 

  30. Picozzi VJ, Kozarek RA, Traverso LW (2003) Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am J Surg 185:476–480

    Article  PubMed  Google Scholar 

  31. Regine WF, Winter KW, Abrams R, et al. (2006) RTOG 9704, a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 24:18S

    Article  Google Scholar 

  32. Splinter TA, Obertop H, Kok TC, et al. (1989) Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study. J Cancer Res Clin Oncol 115:200–202

    Article  PubMed  CAS  Google Scholar 

  33. Staley CA, Lee JE, Cleary KR, et al. (1996) Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171:118–124

    Article  PubMed  CAS  Google Scholar 

  34. Tempero MA, Behrman S, Ben-Josef E, et al. (2005) Pancreatic adenocarcinoma: clinical practice guidelines in oncology. J Natl Compr Canc Netw 3:598–626

    PubMed  Google Scholar 

  35. Trede M, Schwall G, Saeger HD (1990) Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211:447–458

    Article  PubMed  CAS  Google Scholar 

  36. Watanapa P, Williamson RC (1992) Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 79:8–20

    Article  PubMed  CAS  Google Scholar 

  37. Yeo CJ, Abrams RA, Grochow LB, et al. (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 225:621–633

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany

    Lars Roll

Authors
  1. Lars Roll
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Roll, L. (2008). Adjuvant Therapy in Patients with Pancreatic Cancer. In: Pancreatic Cancer. Recent Results in Cancer Research, vol 177. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71279-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-71279-4_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-71266-4

  • Online ISBN: 978-3-540-71279-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation